Cargando…

Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development

Detalles Bibliográficos
Autores principales:	Visser, S A G, Manolis, E, Danhof, M, Kerbusch, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600756/ https://www.ncbi.nlm.nih.gov/pubmed/23835941 http://dx.doi.org/10.1038/psp.2013.3

Ejemplares similares

Translation of Anticancer Efficacy From Nonclinical Models to the Clinic
por: Stroh, M, et al.
Publicado: (2014)

Zika vaccine candidates progress through nonclinical development and enter clinical trials
por: Barrett, Alan D T
Publicado: (2016)

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop
por: Manolis, E, et al.
Publicado: (2013)

International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs
por: Pruimboom‐Brees, Ingrid M., et al.
Publicado: (2023)

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019)

Modeling and Simulation in Clinical Pharmacology and Dose Finding
por: Staab, A, et al.
Publicado: (2013)

Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience
por: Villalona-Calero, Miguel A., et al.
Publicado: (2023)

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective
por: Manolis, Efthymios, et al.
Publicado: (2023)

Overview of the marmoset as a model in nonclinical development of pharmaceutical products
por: Orsi, Antonia, et al.
Publicado: (2011)

Nonclinical Development of BCG Replacement Vaccine Candidates
por: Velmurugan, Kamalakannan, et al.
Publicado: (2013)

Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges
por: Musuamba, Flora T., et al.
Publicado: (2020)

The future of molecular dynamics simulations in drug discovery
por: Borhani, David W., et al.
Publicado: (2011)

Considerations for the Nonclinical Safety Evaluation of Antibody–Drug Conjugates
por: Fisher, J. Edward
Publicado: (2021)

Perspective on model‐informed drug development
por: Lesko, Lawrence J.
Publicado: (2021)

Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization
por: Profico, Daniela Celeste, et al.
Publicado: (2022)

Preparing pathological data to develop an artificial intelligence model in the nonclinical study
por: Hwang, Ji-Hee, et al.
Publicado: (2023)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Paracingulate Sulcus Morphology and Hallucinations in Clinical and Nonclinical Groups
por: Garrison, Jane R, et al.
Publicado: (2019)

A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development
por: Bai, Jane P. F., et al.
Publicado: (2020)

Cryolipolysis: Clinical Best Practices and Other Nonclinical Considerations
por: Few, Julius, et al.
Publicado: (2020)

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
por: Shakhnovich, Valentina, et al.
Publicado: (2019)

Development of COVID-19 therapies: Nonclinical testing considerations
por: Baldrick, Paul
Publicado: (2022)

Molecular Modeling and Simulation Tools in the Development of Peptide-Based Biosensors for Mycotoxin Detection: Example of Ochratoxin
por: Thyparambil, Aby A., et al.
Publicado: (2017)

Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model-Based Drug Development
por: Harnisch, L, et al.
Publicado: (2013)

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop
por: Zhang, X, et al.
Publicado: (2017)

Model Informed Drug Development: Collaboration Through A Common Framework
por: Anziano, Richard J., et al.
Publicado: (2020)

Why 90% of clinical drug development fails and how to improve it?
por: Sun, Duxin, et al.
Publicado: (2022)

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
por: Pollack, Pia S., et al.
Publicado: (2017)

Model Informed Drug Development and Regulation in China: Challenges and Opportunities
por: Li, Li, et al.
Publicado: (2019)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

Modeling the Influence of Nonclinic Visits on the Transmission of Respiratory Diseases
por: Bao, Yunting, et al.
Publicado: (2020)

Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012)

A framework to guide dose & regimen strategy for clinical drug development
por: Sander, Oliver, et al.
Publicado: (2021)

Genetic testing of dogs predicts problem behaviors in clinical and nonclinical samples
por: Zapata, Isain, et al.
Publicado: (2022)

Improving Nonclinical and Clinical-Support Services: Lessons From Oncology
por: Berry, Leonard L., et al.
Publicado: (2018)

A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development
por: Madabushi, Rajanikanth, et al.
Publicado: (2019)

Prediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data
por: Li, Chunze, et al.
Publicado: (2019)

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development
por: Johnson, Trevor N., et al.
Publicado: (2021)

Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models
por: Fernandez, Caridad Ivette, et al.
Publicado: (2017)

Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development
por: Fermini, Bernard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kt89f586vcrgutnrj1i02bg53p